Welcome to our free Open Access Journal!

Annals of Global Medicine is a new, innovative, and diverse archive for medical students, residents/fellows, and attending physicians to share their knowledge of and exposure to interesting clinical cases, treatments, and quality improvement projects. 

  • LinkedIn
  • Instagram

Scope of the Journal 

The Annals of Global Medicine® is the premier international journal of medical, endovascular, and surgical care of all diseases. It is dedicated to the science and art of medicine and surgery and aims to improve the management of patients with rare diseases by publishing relevant papers that report important medical advances, test new hypotheses, and address current controversies. To achieve this goal, the Journal will publish original clinical and laboratory studies, and reports and papers that comment on the social, economic, ethical, legal, and political factors that relate to these aims. As the official publication of the Global Med Review®, the Journal will publish, after careful peer review, selected papers presented at future annual meetings, as well as original articles from members and nonmembers.

Editorial Policies

The editorial policies of the Journal are published in quarterly issues, on the Web site (www.globalmedreview.com), and are available from the Editorial Office on request.

Administrative Policies

Ownership of manuscript.

Manuscripts that are accepted for publication become the property of the Annals of Global Medicine®. They may not be published or reproduced in whole or in part without the written permission of the Publisher.

Permission to reproduce published material.

Permission to reproduce material published in the Annals of Global Medicine®, which is copyrighted by Global Med Review® must be obtained from the Publisher by email at globalmedreview@gmail.com. Authors will be consulted, when possible, regarding the reproduction or republication of their material.

Editors’ and Publisher’s waiver of responsibility.

Statements and opinions expressed in articles and communications herein are those of the author(s) and not necessarily those of the Editors and Publisher. The Editors and Publisher disclaim any responsibility or liability for such material. Neither the Editors nor the Publisher guarantee, warrant, or endorse any product or service advertised in the Journal, and they do not warrant any claim made by the manufacturer of such product or service.

Institutional Review. Manuscripts that involve research conducted on human subjects must follow the principles outlined in the Declaration of Helsinki (http://www.wma.net/e/policy/pdf/17c.pdf) and include a statement in the Methods section that the experimental protocol and informed consent were approved by the Institutional Review Board and that all subjects gave informed consent. Manuscripts that report animal experiments must include a statement in the Methods section that the study was approved by the Institutional Review Board and that the animal care complied with the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Washington: National Academy Press, 1996 (http://stills.nap.edu/readingroom/books/labrats/)

Clinical Trial Registration.

n 2004, the International Committee of Medical Journal Editors (ICMJE) recommended that clinical trials be registered in a public database as a prerequisite for subsequent publication (De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004;351:1250-1). Effective July 1, 2022 the Annals of Global Medicine® will adopt the policies recommended by the ICMJE and require the preregistration of all prospective clinical trials that have a control group (Cronenwett J, Seeger J. Requirement for Registration of Clinical Trials. J Vasc Surg 2007;45:1). In addition, the Journal will also require the preregistration of any commercially sponsored clinical trial, including Phase I and II trials. We do not anticipate the registration of retrospective reviews or summaries of standard clinical treatment. Clinical trials that meet the above requirement and commence after July 1, 2022, must be registered prior to enrollment of the first patient. Relevant trials that began before this date must be registered prior to editorial review. Registration must be indicated by providing the unique study number assigned at www.clinicaltrials.gov, the principal site of registration sponsored by the National Library of Medicine (NLM). Detailed directions and a tutorial for registering a trial are available at http://prsinfo.clinicaltrials.gov. Authors of unregistered trials or those with inadequate information in the registry will be given an opportunity to convince the Editors that their rationale for omitting this was critical, but it is expected that clinical trials involving prospective comparison of treatment or any that are commercially sponsored will all be registered after July 1, 2007.

Manuscript Submissions

The Journal’s requirements for submission of a manuscript are in accordance with the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE) and are available at http://www.icmje.org/icmje-recommendations.pdf. This document is not covered by copyright and can be reproduced and distributed if such use is not for profit. The instructions for authors are summarized below.

General requirements

Length

Clinical and basic research studies must include a structured abstract of 400 words or less. The body of the article must not exceed 3500 words. Tables must be limited to 10 or fewer. Figures must also be limited to 10 or fewer. Each figure and table must have a legend. Note that authors can include additional data (eg, details of methods, statistical analysis, tables, discussions) as appendices that will be published on the Journal’s Web site but not in the print version. The authors are encouraged to submit a 5-minute video summarizing the manuscript. If accepted for publication, this video will accompany the published article. Manuscripts that do not meet these guidelines will be sent back to the authors for editing before review.

Submission of manuscripts

Manuscripts must be submitted to the Annals of Global Medicine® electronically. To submit a manuscript, authors should email all manuscripts, including figures and tables, in multiple files to globalmedreview@gmail.com. To use this system authors must have an Internet connection, an email program, a Web browser, Microsoft Word, and Adobe Acrobat Reader (which can be downloaded at no charge online).

Formatting instructions

Manuscripts must be created using Microsoft Word.

  • Double-space all sections (ie, abstract, text, acknowledgments, references, figure legends, and tables).

  • Use 1-inch margins on all sides.

  • Use 12-point Times New Roman font.

  • Number the pages consecutively in the upper right corner.

Basic information for electronic submission

To submit a manuscript using Microsoft Word, authors must provide the following information:

  • A concise, informative, declarative title;

  • The preferred name(s), initials, and surname of the author(s) and their highest earned academic degrees, listed in the order that these should appear if the manuscript is published;

  • Departmental and institutional affiliations of each author;

  • A completed Application for Publication, including all financial or material support provided to the authors;

  • The meeting, session (ie, plenary session, poster presentation, etc), date, and place where the paper was presented, if applicable;

  • The name and address of the person to whom correspondence is to be addressed;

  • The name and address of the author to whom requests for reprints should be addressed (if reprints will be available).

Material to be submitted after manuscript acceptance

The Copyright Transfer form will be collected by the Publisher. After a manuscript is accepted, the Publisher will contact the corresponding author and send out a form to sign.

For further assistance and clarification, please contact:

Consent to reproduce data

It is the authors’ responsibility to obtain written consent from the copyright owner to reproduce direct quotations, tables, or illustrations that have appeared in copyrighted material and to provide complete information regarding their source. Similarly, permission must be obtained for tables and figures that have been modified from other publications. Such permissions must be obtained prior to manuscript submission and be provided to the Publisher when the Copyright Transfer form is collected. You can obtain permission to reproduce most content from the Copyright Clearance Center at www.copyright.com

Patient consent

Photographs of identifiable persons must be accompanied by signed releases from patients or from both living parents or guardians of minors. As per AMA Style, inserting black bars over the patient’s eyes is insufficient and may not be used. Patient consent must also be obtained from each case report and vascular image patient. 

Description of manuscript components

Title

Titles must be concise and accurately reflect the content of the manuscript. Furthermore, titles must be declarative, stating the topic and results when possible, rather than posing a question. This is important for assisting clinicians and researchers to find the article in Medline once it has been published.

  • DO NOT format the title as a question;

  • DO NOT include a colon in the title or make it two parts using any other punctuation;

  • DO NOT restate the article type (ie, Review, metaanalysis, etc);

  • DO NOT state the type of statistical analysis used, ie multivariate analysis;

  • DO NOT include your Institution Name in the title.

Authors

All of the authors must view and approve the Application for Publication, which is completed by the corresponding author. With this form, the authors certify that they have participated to a sufficient degree to take public responsibility for the work and believe that the manuscript describes truthful facts. The authors also declare that they shall produce the data on which the manuscript is based for examination by the editors or their assignees, should it be requested. Each author also agrees to allow the corresponding author to make decisions regarding submission of the manuscript to the Journal, changes to galley proofs, and prepublication release of information in the manuscript to the media, federal agencies, or both.

Contributors will only be recognized as “authors” if they have made a direct and substantial contribution to the work reported in the manuscript by participating in each of the following three areas:

  • Conceiving and designing the study; or collecting the data; or analyzing and interpreting the data; AND

  • Writing the manuscript or providing critical revisions that are important for the intellectual content; AND

  • Approving the final version of the manuscript; AND

  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Generally, eight is the maximum number of expected authors for a clinical or basic research manuscript. The Editors request that additional authors be carefully examined with respect to the authorship criteria listed above and suggest that some might better be acknowledged than listed as authors. More than eight authors will only be considered for multicenter randomized prospective clinical trials. If your manuscript is not a randomized prospective control trial, requests for additional authors will be denied. As an alternative, a smaller number of key authors may submit the work on behalf of a larger research group, which can then be listed and acknowledged in an appendix. If an author has collaborated on a project but does not meet all the requirements for authorship, he or she should be recognized in the acknowledgment section of the manuscript.

For more information on the requirements for authorship, see the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf), section II.A on Defining the Role of Authors and Contributors. The Journal publishes an Author Contribution Statement at the end of each clinical and basic research manuscript. The information for this statement should be submitted as part of the Application for Publication.

Abstract

A structured abstract is required for all manuscripts except technical notes (which require a shorter, nonstructured abstract), images, special articles, editorials, and presidential addresses. The abstract must be uploaded as a separate file from the rest of the manuscript and must include the title of the manuscript, the names of the authors, affiliations, and contact information for the corresponding author. The abstract replaces the summary and ordinarily should clearly state, in approximately 250 words (but never more than 400 words), the main factual points of the article. The abstract should be informative, not descriptive. Detailed results should be included in the abstract since many readers only have access to abstracts and not the entire article. A structured abstract will include combinations of the following headings that apply and are informative, as described in detail in previous publications (Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardiner MJ. More informative abstracts revisited. Ann Intern Med 1990;113:69-76. Ad Hoc Working Group For Critical Appraisal of the Medical Literature. A proposal for more informative abstracts of clinical articles. Ann Intern Med 1987;106:598-604).

Typical abstract headings include:

  • Introduction: including a precise statement of the exact question(s) addressed by the study and, if appropriate, the hypothesis

  • Methods: the basic study design and setting (ie, community referral center, ambulatory or hospitalized patients), the patient/subject selection method and number, eligibility criteria, proportion withdrawn, and the exact treatment or interventions

  • Results: main outcome measure(s), the main results should be stated with statistical significance

  • Conclusions: only conclusions supported by the study and their clinical application may be stated

Tables

Figures, reference citations, and trademarked names should not appear in the abstract. Since many readers only have access to the abstract, it is essential that it contain numerical results and not simply summary conclusions.

Clinical Relevance 

For Basic Research Studies, the Journal includes a paragraph describing the clinical relevance of all published basic research articles. This will be printed immediately below the Conclusions section of the abstract of the article, but will not be included in the Abstract available on Medline. The purpose of this section is to interest clinical surgeons in reading this work and help them understand its significance. Basic Research authors must submit a paragraph of approximately 100 words entitled “Clinical Relevance” in which they relate the basic research study they are reporting to its current or future clinical applications.

Text. Manuscripts must conform to standard English usage and are subject to editing in conformance with the policies of the Journal. For reference, authors may consult the American Medical Association’s Manual of Style, 10th Edition.

Manuscript body

The manuscript, including the abstract, must be uploaded as a separate file using Editorial Manager. The usual sections for a manuscript include Introduction, Methods, Results, Discussion, and Conclusions. Subheadings may be useful and help clarify the content in longer papers. Methods must be described in sufficient detail to allow others to reproduce the work. For established methods, appropriate references and a brief description are sufficient; but for new methods, appropriate details are required. If the description of the method is very long, the techniques should be summarized and referenced and the details provided as an appendix that will be published on the Web but not in print.

For human studies, the following details are generally important: eligibility (inclusion and exclusion criteria), randomization method, blinding methods, total consecutive patients enrolled, and the number of exclusions or dropouts and reasons.

For randomized controlled trials, the CONSORT document provides reporting guidelines that should be met in articles submitted to the Journal (CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Lancet, Published online March 24, 2010 Webappendix). Lancet 2001;357:1191-4). Full details are available at http://www.consort-statement.org/. This article provides a checklist of the items that should be included in the report of the methods, results, and discussion and the suggested details of a flow diagram that gives information on patient flow through the study. Observational studies should include these details as well.

Reporting standards have been published that provide guidelines for reporting meta-analyses of the randomized controlled studies (Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUORUM statement. Lancet 1999;354:1896-900) and observational studies (Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12).

Manuscripts involving research conducted on human subjects and/or that report animal experiments must follow all requirements listed in the Institutional Review section above. Details of the statistical methods should be referenced and, if uncommon, the principles explained. If a manuscript is considered acceptable for publication, the Editors may choose to subject it to formal statistical review to ensure that the study population was clearly defined, that the design of the study was suitable, that appropriate statistical methods were used, and that the subsequent conclusions were supported.

Generic drug names should be used, specifically the United States Adopted Name (USAN). Proprietary drug names may be cited in parentheses. Generic equipment names should be used whenever possible and the proprietary name of the equipment cited in parentheses; after the proprietary name, cite the manufacturer and the city, state, and country of manufacture.

Measurements (height, weight, etc,) should be stated in metric units. Hematologic and clinical chemistry measurements can be stated in System International (SI) units or non-SI units. Note that SI units are recommended in the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf).

Only standard abbreviations should be used; avoid unusual or coined abbreviations. The first time any abbreviation is used it should be included in parentheses after the words it replaces. Abbreviations should not be used in the title or abstract.

Acknowledgments 

Acknowledgments should include collaborators, if they give written permission to be acknowledged, and technical and secretarial assistance, as appropriate.

References. Cite references selectively; an extensive literature review is rarely necessary, and only pertinent references should be given (ie, those that provide the basis for a key statement). References should be cited consecutively in the text by superscript Arabic numbers in the order in which they are first mentioned in the text, a table, or a figure. References should not be cited alphabetically. The reference list should be typed double-spaced. References to articles in press must include authors’ names, title of the article, and name of the journal. Personal communications and unpublished data are not to be cited as references; instead, indicate these sources in the text at the appropriate place and include the individual’s preferred given name, initials, surname, title, city, and year of communication. Append to the manuscript a note of approval from the source for the statement. Make sure all references have been verified. The accuracy of the references, including the spelling of references in foreign languages, is the responsibility of the authors and is crucial so that they can be linked to the original citation in the Web version. Abbreviate journal names according to the Index Medicus. Authors should be certain that all references use the standard abbreviated journal names according to the Index Medicus. This is imperative to ensure accurate linking of references in the online version of the Journal. References that do not use the standard abbreviated journal names will not link. If there are six or fewer authors, list all; if seven or more, list only the first six, then et al. The format for references is described in detail in Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf). Examples follow:

Format for journal articles: Josa M, Khuri SF, Braunwald NS, VanCisin MF, Spencer MP, Evans DA, et al. Delayed sternal closure: an improved method of dealing with complications after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986;91:598-603.

Format for books: Berger HJ, Zaret BL, Cohen LS. Cardiovascular nuclear medicine. In: Goldberger E, editor. Textbook of clinical cardiology. 1st ed. St Louis: CV Mosby; 1982. p. 326-45.

Tables 

Tables should supplement, not duplicate, the text. Number them consecutively in Roman numerals according to their order of citation in the text. Because tables should be self-explanatory, provide a brief caption for each table. Each table should be double-spaced and uploaded to Editorial Manager as a separate file. Abbreviations used in the table should be explained in a footnote; however, abbreviations that have been defined in the body of the text do not need to be spelled out or explained in the table. If a table or any data therein have been previously published, a footnote in the table must give full credit to the original source, and the original publisher’s permission to reproduce the table must be provided.

Illustrations 

Limit illustrations to those that amplify, not duplicate, the text. A reasonable number of line or halftone illustrations will be reproduced. Inclusion of color illustrations is at the discretion of the Editor. Original drawings or graphs should be prepared by computer methods or by a professional artist. Detailed artwork instructions and help with formatting, sizing, scanning, and file naming can be found at the Elsevier Author Gateway at http://authors.elsevier.com/.

Operative and pathology photographs should be in color. Other figures and charts should be black and white unless sufficiently complex to require color.

Figure legends

Type legends are double-spaced in one separate Word file. Indicate original magnification and stain for photomicrographs. If a figure has been previously published, the legend must give full credit to the original source and a letter from the original source giving permission to reproduce the figure must be submitted.

Videos

Format: All videos should be in MP4 format. The preferred codec is H264. Please do not submit videos that exceed 150 MB. Authors will be notified if there are any problems with submitted files and asked to resubmit modified files. Image editing and correct formatting are the author's responsibility.

Author Summaries: Authors of Clinical, Basic Research, and Review articles are encouraged to submit a 5 minute video summary of their manuscript.

Video Demonstrations: Authors should consider adding narration or explanatory captioning to video demonstrations of new techniques and procedures.

AudioSlides: AudioSlides are short, Webcast-style presentations that are shown next to online articles on ScienceDirect. This format gives authors the opportunity to present their research in their own words, helping readers understand quickly what a paper is about and determine its relevance. After acceptance, the authors will have the option to add AudioSlides to their published manuscript. This feature is complimentary. More information about AudioSlides will be provided to you if your manuscript is accepted for publication.

Publication: As with all other manuscript files, videos must be the original unpublished work of the authors. By submitting your manuscript and video files to the Annals of Global Medicine, the authors agree to allow the publication of the manuscript files, including the video files by the Journal.

 

Statistical analysis. In reports that contain statistically analyzed data, the corresponding author must identify, in the Application for Publication, the coauthor or consultant who was responsible for the statistical analysis.

Manuscript Acceptance

Role of the Publisher

Author Proofs and Copyright Transfer Forms

The Publisher will edit and send out Author Proofs only to corresponding authors. Corrections to these proofs must be returned to the Publisher within 1 week. The Publisher is responsible for sending and receiving Copyright Transfer Forms. Any delay in the return of page proofs and Copyright Transfer Forms to the Publisher will result in a delay of article placement on the Journal website.  

Publication Format

After a manuscript has been peer-reviewed and accepted for publication, the authors must agree to publish their research in an open-access format. Fees for this service are collected by the Publisher, and will have no bearing on the peer review or acceptance process. 

Open Access

  • Articles are freely available to both subscribers and the wider public with permitted reuse

  • An Open Access publication fee is payable by authors or their research funder

 

The Annals of Global Medicine® is US $300, excluding taxes. Learn more about Elsevier’s pricing policy: http://www.elsevier.com/openaccesspricing.

 

Are you ready to be published?

Please send us your submissions, or contact us with any questions regarding publications or submissions.